The Q1 financial results announcement for the fiscal year ending March 2027 has been postponed while investigating uncertainties in the accounting treatment of Takara Bio USA, Inc. The new Q1 announcement date is October 23, 2026, and the Q2 results are scheduled to be announced on November 10, 2026.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"2531","jir_company_name":"Takara Holdings Inc.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-10-20","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/10\/2531-20261020-01.pdf","jir_short_summary":"The Q1 financial results announcement for the fiscal year ending March 2027 has been postponed while investigating uncertainties in the accounting treatment of Takara Bio USA, Inc. The new Q1 announcement date is October 23, 2026, and the Q2 results are scheduled to be announced on November 10, 2026.","jir_summary":"### Background of Delay and Investigation\nFollowing a notice published on August 12, 2026 that disclosure of the Q1 financial summary for the fiscal year ending March 2027 would exceed 45 days after the quarter-end, the company has been investigating uncertainties in the accounting treatment of Takara Bio USA, Inc. With the investigation completed and a timeline for the financial announcement established, the company has set the Q1 financial results announcement date to October 23, 2026. The Q2 financial results are scheduled to be announced on November 10, 2026.\n\n### Future Schedule and Shareholder Communication\nThe company apologizes for any confusion caused to shareholders and investors by the change in the announcement date. The scheduled Q2 announcement date has also been disclosed, and the company intends to continue timely disclosure of information.","jir_financial_highlights":"Announcement Date: October 23, 2026 (Rescheduled date)","jir_category":"","jir_hashtags":"#TakaraHoldings, #FinancialResults, #AnnouncementDelay","jir_key_figures":"Announcement Date: 2026-10-23\nQ2 Financial Results Announcement Date: 2026-11-10","jir_meta_title":"Takara Holdings Inc. - Notice of Postponement of Q1 FY2027 Financial Results Announcement | October 2026","jir_meta_description":"Takara Holdings Inc. has postponed the Q1 financial results announcement for FY ending March 2027 while completing an investigation into the accounting treatment of Takara Bio USA. Q1 results are scheduled for October 23, 2026; Q2 results are scheduled for November 10, 2026.","jir_og_title":"Takara Holdings Inc. | Notice of Postponement of Financial Results Announcement","jir_og_description":"Takara Holdings Inc. has postponed the Q1 FY2027 financial results announcement, announced completion of the investigation and disclosed a revised announcement schedule. Q2 results are scheduled for November 10, 2026.","jir_og_image_url":"\/assets\/og\/company-financial_summary.jpg","jir_chart_data_collection":"[]","ir_related_company":8130,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-132847","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n